Nutritional and metabolic factors in amyotrophic lateral sclerosis

A Ludolph, L Dupuis, E Kasarskis, F Steyn… - Nature Reviews …, 2023 - nature.com
Amyotrophic lateral sclerosis (ALS) is a complex neurodegenerative disease that is
classically thought to impact the motor system. Over the past 20 years, research has started …

The panoramic view of amyotrophic lateral sclerosis: A fatal intricate neurological disorder

S Dhasmana, A Dhasmana, AS Narula, M Jaggi… - Life Sciences, 2022 - Elsevier
Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neurological disease affecting
both upper and lower motor neurons. In the United States alone, there are 16,000–20,000 …

Brain vascular health in ALS is mediated through motor cortex microvascular integrity

S Schreiber, J Bernal, P Arndt, F Schreiber, P Müller… - Cells, 2023 - mdpi.com
Brain vascular health appears to be critical for preventing the development of amyotrophic
lateral sclerosis (ALS) and slowing its progression. ALS patients often demonstrate …

Cystatin C based estimation of chronic kidney disease and amyotrophic lateral sclerosis in the ALS registry Swabia: associated risk and prognostic value

G Nagel, D Kurz, RS Peter, A Rosenbohm, W Koenig… - Scientific Reports, 2023 - nature.com
Kidney function as part of metabolic changes could be associated with amyotrophic lateral-
sclerosis (ALS). We investigated the associations between estimated chronic kidney disease …

Medications on hypertension, hyperlipidemia, diabetes, and risk of amyotrophic lateral sclerosis: A systematic review and meta-analysis

N Hu, H Ji - Neurological Sciences, 2022 - Springer
Objective To investigate the association between the use of common medications on
hypertension, hyperlipidemia, diabetes, and the risk of amyotrophic lateral sclerosis (ALS) …

Symptoms timeline and outcomes in amyotrophic lateral sclerosis using artificial intelligence

T Segura, IH Medrano, S Collazo, C Maté, C Sguera… - Scientific Reports, 2023 - nature.com
Amyotrophic lateral sclerosis (ALS) is a fatal, neurodegenerative motor neuron disease.
Although an early diagnosis is crucial to provide adequate care and improve survival …

Medication use and risk of amyotrophic lateral sclerosis—a systematic review

C Cui, J Sun, KA McKay, C Ingre, F Fang - BMC medicine, 2022 - Springer
Background Studying whether medications act as potential risk factors for amyotrophic
lateral sclerosis (ALS) can contribute to the understanding of disease etiology as well as the …

Association between cardiometabolic diseases and the risk and progression of motor neuron diseases in Sweden: a population-based case–control study

C Chourpiliadis, A Lovik, C Seitz, Y Hu… - The Lancet Regional …, 2025 - thelancet.com
Background The evidence on the link between cardiometabolic diseases (CMDs) and motor
neuron diseases (MNDs) remains inconsistent. We aimed to determine whether there is an …

Physical activity as risk factor in amyotrophic lateral sclerosis: a systematic review and meta-analysis

X Zheng, S Wang, J Huang, J Lin, T Yang, Y Xiao… - Journal of …, 2023 - Springer
Objective Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder with
rapid progression and high mortality. Physical activity (PA) has been identified as a major …

Risk factors of amyotrophic lateral sclerosis: a global meta-summary

QQ Duan, Z Jiang, WM Su, XJ Gu, H Wang… - Frontiers in …, 2023 - frontiersin.org
Background The etiology of amyotrophic lateral sclerosis (ALS) remains largely unknown.
This study aimed to summarize the relationship between ALS and its genetic and non …